Stephanie MC Wilson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stephanie MC Wilson has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
Ryan P Lowery
The University of Tampa, Tampa, Florida, USA
12 shared publicationsSean A McCleary
The University of Tampa, Tampa, Florida, USA
8 shared publications- Ryan P. Lowery
Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL 33606, USA
7 shared publications Jacob M Wilson
Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL, USA
5 shared publicationsJeremy P. Loenneke
Department of Health and Exercise Science University of Oklahoma Norman OK USA
5 shared publications- Jordan M. Joy
Department of Health Sciences and Human Performance, The University of Tampa, Tampa, FL 33606, USA
5 shared publications
Latest Publications
- Open Access
- 16 August 2015
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 12 (1) , 1-11
Effects of oral phosphatidic acid feeding with or without whey protein on muscle protein synthesis and anabolic signaling in rodent skeletal muscle
Phosphatidic acid (PA) is a diacyl-glycerophospholipid that acts as a signaling molecule in numerous cellular processes. Recently, PA has been proposed to stimulate skeletal muscle protein accretion, but mechanistic studies are lacking. Furthermore, it is unknown whether co-ingesting PA with other leucine-containing ingredients can enhance intramuscular anabolic signaling mechanisms. Thus, the purpose of this study was to examine if oral PA feeding acutely increases anabolic signaling markers and muscle protein synthesis (MPS) in gastrocnemius with and without whey protein concentrate (WPC). Overnight fasted male Wistar rats (~250 g) were randomly assigned to four groups: control (CON, n = 6-13), PA (29 mg; n = 8), WPC (197 mg; n = 8), or PA + WPC (n = 8). Three hours post-feeding, gastrocnemius muscle was removed for markers of Akt-mTOR signaling, gene expression patterns related to skeletal muscle mass regulation and metabolism, and MPS analysis via the SUnSET method. Compared to CON rats, PA, WPC and PA + WPC resulted in a significant elevation in the phosphorylation of mTOR (Ser2481) and rps6 (Ser235/236) (p < 0.05) in the gastrocnemius though there were no differences between the supplemented groups. MPS levels in the gastrocnemius were significantly (p < 0.05) elevated in WPC versus CON rats, and tended to be elevated in PA versus CON rats (p = 0.08), though MPS was less in PA + WPC versus WPC rats (p < 0.05) in spite of robust increases in mTOR pathway activity markers in the former group. C2C12 myoblast data agreed with the in vivo data herein showing that PA increased MPS levels 51 % (p < 0.001) phosphorylated p70s6k (Thr389) levels 67 % (p < 0.001). Our results are the first in vivo evidence to demonstrate that PA tends to increases MPS 3 h post-feeding, though PA may delay WPC-mediated MPS kinetics within a 3 h post-feeding window.
- 16 August 2015
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 12 (1) , 1-11
Open AccessEffects of oral phosphatidic acid feeding with or without whey protein on muscle protein synthesis and anabolic signaling in rodent skeletal muscle
Phosphatidic acid (PA) is a diacyl-glycerophospholipid that acts as a signaling molecule in numerous cellular processes. Recently, PA has been proposed to stimulate skeletal muscle protein accretion, but mechanistic studies are lacking. Furthermore, it is unknown whether co-ingesting PA with other leucine-containing ingredients can enhance intramuscular anabolic signaling mechanisms. Thus, the purpose of this study was to examine if oral PA feeding acutely increases anabolic signaling markers and muscle protein synthesis (MPS) in gastrocnemius with and without whey protein concentrate (WPC). Overnight fasted male Wistar rats (~250 g) were randomly assigned to four groups: control (CON, n = 6-13), PA (29 mg; n = 8), WPC (197 mg; n = 8), or PA + WPC (n = 8). Three hours post-feeding, gastrocnemius muscle was removed for markers of Akt-mTOR signaling, gene expression patterns related to skeletal muscle mass regulation and metabolism, and MPS analysis via the SUnSET method. Compared to CON rats, PA, WPC and PA + WPC resulted in a significant elevation in the phosphorylation of mTOR (Ser2481) and rps6 (Ser235/236) (p < 0.05) in the gastrocnemius though there were no differences between the supplemented groups. MPS levels in the gastrocnemius were significantly (p < 0.05) elevated in WPC versus CON rats, and tended to be elevated in PA versus CON rats (p = 0.08), though MPS was less in PA + WPC versus WPC rats (p < 0.05) in spite of robust increases in mTOR pathway activity markers in the former group. C2C12 myoblast data agreed with the in vivo data herein showing that PA increased MPS levels 51 % (p < 0.001) phosphorylated p70s6k (Thr389) levels 67 % (p < 0.001). Our results are the first in vivo evidence to demonstrate that PA tends to increases MPS 3 h post-feeding, though PA may delay WPC-mediated MPS kinetics within a 3 h post-feeding window.
- Open Access
- 1 December 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (sup1) , P44
The effects of t-bomb II on lean body mass and hormonal profile in resistance trained athletes
- 1 December 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (sup1) , P44
Open AccessThe effects of t-bomb II on lean body mass and hormonal profile in resistance trained athletes
- Open Access
- 1 December 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (sup1) , P43
Impact of glycogen resynthesis on lean mass
- 1 December 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (sup1) , P43
Open AccessImpact of glycogen resynthesis on lean mass
- Open Access
- 1 December 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (sup1) , P42
The effects of a myostatin inhibitor on lean body mass, strength, and power in resistance trained males
- 1 December 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (sup1) , P42
Open AccessThe effects of a myostatin inhibitor on lean body mass, strength, and power in resistance trained males
- Open Access
- 1 December 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (sup1) , P41
Effects of a ketogenic diet on strength and power
- 1 December 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (sup1) , P41
Open AccessEffects of a ketogenic diet on strength and power
- Open Access
- 1 December 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (sup1) , P40
The effects of ketogenic dieting on skeletal muscle and fat mass
- 1 December 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (sup1) , P40
Open AccessThe effects of ketogenic dieting on skeletal muscle and fat mass
- Open Access
- 1 December 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (sup1) , P38
The effects of probiotic supplementation on lean body mass, strength, and power, and health indicators in resistance trained males: a pilot study
- 1 December 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (sup1) , P38
Open AccessThe effects of probiotic supplementation on lean body mass, strength, and power, and health indicators in resistance trained males: a pilot study
- Open Access
- 15 August 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (1) , 60
28 days of creatine nitrate supplementation is apparently safe in healthy individuals
Creatine monohydrate has become a very popular nutritional supplement for its ergogenic effects. The safety of creatine monohydrate has previously been confirmed. However with each novel form of creatine that emerges, its safety must be verified. Therefore, the purpose of this study was to examine the safety of a novel form of creatine, creatine nitrate (CN), over a 28 day period. 58 young males and females (Pooled: 24.3 ± 3.9 years, 144.9 ± 8.0 cm, 74.2 ± 13.0 kg) participated in this study across two laboratories. Subjects were equally and randomly assigned to consume either 1 g (n = 18) or 2 g (n = 20) of CN or remained unsupplemented (n = 20). Blood draws for full safety panels were conducted by a trained phlebotomist prior to and at the conclusion of the supplementation period. Pooled data from both laboratories revealed significant group x time interactions for absolute lymphocytes and absolute monocytes (p < 0.05). Analysis of the 1 g treatment revealed lab x time differences for red blood cell distribution width, platelets, absolute monocytes, creatinine, blood urea nitrogen (BUN):creatinine, sodium, protein, and alanine aminotransferase (ALT) (p < 0.05). Analysis of the 2 g treatment revealed lab x time differences for BUN:creatinine and ALT (p < 0.05). BUN and BUN:creatinine increased beyond the clinical reference range for the 2 g treatment of Lab 2, but BUN did not reach statistical significance. Overall, CN appears to be safe in both 1 g and 2 g servings daily for up to a 28 day period. While those with previously elevated BUN levels may see additional increases resulting in post-supplementation values slightly beyond normal physiological range, these results have minor clinical significance and are not cause for concern. Otherwise, all hematological safety markers remained within normal range, suggesting that CN supplementation has no adverse effects in daily doses up to 2 g over 28 days and may be an alternative to creatine monohydrate supplementation.
- 15 August 2014
- Published by Taylor & Francis in Journal of the International Society of Sports Nutrition
- Vol. 11 (1) , 60
Open Access28 days of creatine nitrate supplementation is apparently safe in healthy individuals
Creatine monohydrate has become a very popular nutritional supplement for its ergogenic effects. The safety of creatine monohydrate has previously been confirmed. However with each novel form of creatine that emerges, its safety must be verified. Therefore, the purpose of this study was to examine the safety of a novel form of creatine, creatine nitrate (CN), over a 28 day period. 58 young males and females (Pooled: 24.3 ± 3.9 years, 144.9 ± 8.0 cm, 74.2 ± 13.0 kg) participated in this study across two laboratories. Subjects were equally and randomly assigned to consume either 1 g (n = 18) or 2 g (n = 20) of CN or remained unsupplemented (n = 20). Blood draws for full safety panels were conducted by a trained phlebotomist prior to and at the conclusion of the supplementation period. Pooled data from both laboratories revealed significant group x time interactions for absolute lymphocytes and absolute monocytes (p < 0.05). Analysis of the 1 g treatment revealed lab x time differences for red blood cell distribution width, platelets, absolute monocytes, creatinine, blood urea nitrogen (BUN):creatinine, sodium, protein, and alanine aminotransferase (ALT) (p < 0.05). Analysis of the 2 g treatment revealed lab x time differences for BUN:creatinine and ALT (p < 0.05). BUN and BUN:creatinine increased beyond the clinical reference range for the 2 g treatment of Lab 2, but BUN did not reach statistical significance. Overall, CN appears to be safe in both 1 g and 2 g servings daily for up to a 28 day period. While those with previously elevated BUN levels may see additional increases resulting in post-supplementation values slightly beyond normal physiological range, these results have minor clinical significance and are not cause for concern. Otherwise, all hematological safety markers remained within normal range, suggesting that CN supplementation has no adverse effects in daily doses up to 2 g over 28 days and may be an alternative to creatine monohydrate supplementation.
- Open Access
- 16 June 2014
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 11 (1) , 29
Phosphatidic acid enhances mTOR signaling and resistance exercise induced hypertrophy
The lipid messenger phosphatidic acid (PA) plays a critical role in the stimulation of mTOR signaling. However, the mechanism by which PA stimulates mTOR is currently unknown. Therefore, the purpose of this study was to compare the effects of various PA precursors and phospholipids on their ability to stimulate mTOR signaling and its ability to augment resistance training-induced changes in body composition and performance.
- 16 June 2014
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 11 (1) , 29
Open AccessPhosphatidic acid enhances mTOR signaling and resistance exercise induced hypertrophy
The lipid messenger phosphatidic acid (PA) plays a critical role in the stimulation of mTOR signaling. However, the mechanism by which PA stimulates mTOR is currently unknown. Therefore, the purpose of this study was to compare the effects of various PA precursors and phospholipids on their ability to stimulate mTOR signaling and its ability to augment resistance training-induced changes in body composition and performance.
- Open Access
- 24 January 2014
- Published by Springer Nature in Nutrition Journal
- Vol. 13 (1) , 11
Comparative absorption of curcumin formulations
The potential health benefits of curcumin are limited by its poor solubility, low absorption from the gut, rapid metabolism and rapid systemic elimination. The purpose of this study was the comparative measurement of the increases in levels of curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin) and the metabolite tetrahydrocurcumin after oral administration of three different curcumin formulations in comparison to unformulated standard.
- 24 January 2014
- Published by Springer Nature in Nutrition Journal
- Vol. 13 (1) , 11
Open AccessComparative absorption of curcumin formulations
The potential health benefits of curcumin are limited by its poor solubility, low absorption from the gut, rapid metabolism and rapid systemic elimination. The purpose of this study was the comparative measurement of the increases in levels of curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin) and the metabolite tetrahydrocurcumin after oral administration of three different curcumin formulations in comparison to unformulated standard.